Yes, we're on the same page with that forecast. Under promise, over deliver. I've held since 2010 & they've met or beaten their forecast NPAT every year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025